Intellia Therapeutics
NTLA
NTLA
335 hedge funds and large institutions have $10B invested in Intellia Therapeutics in 2021 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 89 increasing their positions, 113 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
29% more funds holding
Funds holding: 260 → 335 (+75)
1.89% less ownership
Funds ownership: 93.31% → 91.42% (-1.9%)
21% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 113
Holders
335
Holding in Top 10
12
Calls
$461M
Puts
$335M
Top Buyers
| 1 | +$301M | |
| 2 | +$255M | |
| 3 | +$158M | |
| 4 |
DVF
Discovery Value Fund
Singapore
|
+$127M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$75M |
Top Sellers
| 1 | -$312M | |
| 2 | -$295M | |
| 3 | -$272M | |
| 4 |
AVAI
Atlas Venture Associates IX
Boston,
Massachusetts
|
-$179M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$88.8M |